The Pharma Industry registered 15% growth in Q1 2023 during which the Chronic and Acute therapies both grew at same rate. Some of the key trends of Pharma Industry for Q1 2023 are as below –
- Chronic therapies growth of 15% was mainly due to Cardiac followed by Chronic respiratory and Neuro/ CNS
- Acute market growth of 15% majorly due to growth from AI, Pain, and GI therapies
- Indian Pharma companies grew faster compared to the MNCs
- Number of new launches have increased by 26% in 2023 as compared to 2022